K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells
Jung Il Lee,Kwan Sik Lee,Yong Han Paik,Young Nyun Park,Kwang Hyub Han,Chae Yoon Chon,Young Myoung Moon +6 more
TL;DR: Studying apoptosis using apoptotic HSCs isolated by a usual density gradient centrifugation method from injured tissue sections would be feasible since it correlated with in vivo apoptosis of HSC.
Journal ArticleDOI
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
Hye Soo Kim,Beom Kyung Kim,Seung Up Kim,Jun Yong Park,Do Young Kim,Kijun Song,Jung Won Park,Yeong Jin Kim,Oidov Baatarkhuu,Kwang Hyub Han,Sang Hoon Ahn +10 more
TL;DR: In a PSM analysis, level of fibrosis, rather than antiviral regimen, is associated with risk of HCC, when patients received appropriate rescue therapy in case of virologic breakthrough or resistance mutations.
Journal ArticleDOI
Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study.
Oidov Baatarkhuu,Do Young Kim,Sang Hoon Ahn,Pagvajav Nymadawa,Yagaanbuyant Dahgwahdorj,Manaljav Shagdarsuren,Jun Yong Park,Jongwon Choi,Janchiv Oyunbileg,Tsendsuren Oyunsuren,Kwang Hyub Han +10 more
TL;DR: Investigation of the population‐based prevalence of HCV infection and genotype distribution among 1512 apparently healthy individuals in Mongolia found no data concerning nationwide prevalence ofHCV infection in Mongolia.
Journal ArticleDOI
Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea
Yong Han Paik,Hyo Young Chung,Wang-Shick Ryu,Kwan Sik Lee,Jisook Lee,Jung Hee Kim,Chun Kyun Lee,Chae Yoon Chon,Young Myoung Moon,Kwang Hyub Han +9 more
TL;DR: YMDD mutants in HBV were detected within a few weeks during lamivudine therapy in South Korea, which suggests that the YMDD mutant may exist even before lamivirulence therapy in hepatitis B virus endemic areas.
Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
Kyu Sik Jung,Beom Kyung Kim,Seung Up Kim,Young Eun Chon,Kyung Hyun Cheon,Sung Bae Kim,Sang Hoon Lee,Sung Soo Ahn,Jun Yong Park,Do Young Kim,Sanghoon Ahn,Young Nyun Park,Kwang Hyub Han +12 more
TL;DR: Patients with high grade steatosis or high CAP values have a higher risk of discordance between LB and CAP, reflected by histological activity or ALT level.